| Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential A Kazanets, T Shorstova, K Hilmi, M Marques, M Witcher Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1865 (2), 275-288, 2016 | 230 | 2016 |
| Anticancer Properties of Phyllanthus emblica (Indian Gooseberry) T Zhao, Q Sun, M Marques, M Witcher Oxidative medicine and cellular longevity 2015 (1), 950890, 2015 | 150 | 2015 |
| Reconciling the positive and negative roles of histone H2A. Z in gene transcription M Marques, L Laflamme, AL Gervais, L Gaudreau Epigenetics 5 (4), 267-272, 2010 | 132 | 2010 |
| Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors CA Philip, I Laskov, MC Beauchamp, M Marques, O Amin, J Bitharas, ... BMC cancer 17, 1-11, 2017 | 109 | 2017 |
| Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I R Peña-Hernández, M Marques, K Hilmi, T Zhao, A Saad, ... Proceedings of the National Academy of Sciences 112 (7), E677-E686, 2015 | 91 | 2015 |
| Estrogen receptor α can selectively repress dioxin receptor-mediated gene expression by targeting DNA methylation M Marques, L Laflamme, L Gaudreau Nucleic acids research 41 (17), 8094-8106, 2013 | 88 | 2013 |
| CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair K Hilmi, M Jangal, M Marques, T Zhao, A Saad, C Zhang, VM Luo, ... Science advances 3 (5), e1601898, 2017 | 85 | 2017 |
| SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors T Shorstova, M Marques, J Su, J Johnston, CL Kleinman, N Hamel, ... Cancer research 79 (10), 2761-2774, 2019 | 72 | 2019 |
| Competition between translation initiation factor eIF5 and its mimic protein 5MP determines non-AUG initiation rate genome-wide L Tang, J Morris, J Wan, C Moore, Y Fujita, S Gillaspie, E Aube, J Nanda, ... Nucleic acids research 45 (20), 11941-11953, 2017 | 68 | 2017 |
| Haploinsufficiency of the ESCRT component HD-PTP predisposes to cancer S Manteghi, MC Gingras, D Kharitidi, L Galarneau, M Marques, M Yan, ... Cell reports 15 (9), 1893-1900, 2016 | 55 | 2016 |
| Low levels of 3, 3′-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol M Marques, L Laflamme, I Benassou, C Cissokho, B Guillemette, ... BMC cancer 14, 1-10, 2014 | 51 | 2014 |
| Phosphoinositide 3-kinase and Forkhead, a switch for cell division L Martinez-Gac, B Alvarez, Z Garcia, M Marques, M Arrizabalaga, ... Biochemical Society Transactions 32 (2), 360-361, 2004 | 45 | 2004 |
| Bsr, a nuclear-retained RNA with monoallelic expression H Royo, E Basyuk, V Marty, M Marques, E Bertrand, J Cavaillé Molecular biology of the cell 18 (8), 2817-2827, 2007 | 39 | 2007 |
| Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo T Zhao, Q Sun, SV del Rincon, A Lovato, M Marques, M Witcher PloS one 9 (3), e92853, 2014 | 38 | 2014 |
| MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ Q Guo, VZ Li, JN Nichol, F Huang, W Yang, SEJ Preston, Z Talat, ... Cancer research 79 (7), 1646-1657, 2019 | 37 | 2019 |
| PCRTiler: automated design of tiled and specific PCR primer pairs AL Gervais, M Marques, L Gaudreau Nucleic acids research 38 (suppl_2), W308-W312, 2010 | 36 | 2010 |
| Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors M Marques, MC Beauchamp, H Fleury, I Laskov, S Qiang, M Pelmus, ... BMC medicine 13, 1-8, 2015 | 32 | 2015 |
| Insights into a novel nuclear function for Fascin in the regulation of the amino-acid transporter SLC3A2 A Saad, K Bijian, D Qiu, SD Da Silva, M Marques, CH Chang, H Nassour, ... Scientific reports 6 (1), 36699, 2016 | 31 | 2016 |
| Oncogenic activity of poly (ADP-ribose) glycohydrolase M Marques, M Jangal, LC Wang, A Kazanets, SD da Silva, T Zhao, ... Oncogene 38 (12), 2177-2191, 2019 | 30 | 2019 |
| Analysis of the genomic landscape in ALK+ NSCLC patients identifies novel aberrations associated with clinical outcomes M Couëtoux du Tertre, M Marques, L Tremblay, N Bouchard, ... Molecular Cancer Therapeutics 18 (9), 1628-1636, 2019 | 23 | 2019 |
